Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Mugsy is wright

<< Previous

Bullboard Posts

Next >>

Post by Duster340on Apr 22, 2022 1:53pm

148 Views

Post# 34624510

Mugsy is wright

nothing more than fear in the market + the bnn talking heads adding to the negativity. likely ate will bounce back on monday if the market is in the green. it is a buying opportunity if you think the market has bottomed, (the time to buy is when everyone else is selling (warren buffet) every one has to make there own decission.
glta

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs